Nitrosamine Impurities management is a critical component of pharmaceutical compliance, focusing on the rigorous detection, risk assessment, and mitigation of potentially mutagenic compounds within drug formulations. By leveraging advanced analytical testing methodologies and robust root-cause investigations, industry professionals can effectively ensure drug safety and maintain adherence to stringent global regulatory standards. The USP Exchange Nitrosamines community serves as an authoritative, collaborative forum for scientists to share complex mitigation strategies, evaluate toxicological assessments, and proactively align on evolving compendial guidelines.

Extractables and Leachables (EnL) studies are a critical component of pharmaceutical compliance, dedicated to evaluating chemical impurities that may migrate from packaging materials, delivery devices, or manufacturing systems into final drug products. By leveraging advanced analytical techniques—such as mass spectrometry and chromatography—these rigorous material science assessments are essential for ensuring patient safety and maintaining product efficacy. The USP E&L Exchange community serves as an authoritative, centralized forum for industry professionals to collaboratively navigate complex testing methodologies and stay ahead of evolving global regulatory standards.

Quantitative Nuclear Magnetic Resonance (qNMR) is a premier analytical technique for pharmaceutical compliance, delivering highly accurate, primary ratio measurements for purity determination and molecular structural verification without the absolute requirement for identical reference standards. By leveraging robust metrological principles and advanced spectroscopic methodologies, industry professionals utilize qNMR to ensure exact quantitation, streamline quality control processes, and maintain strict adherence to global compendial guidelines. The USP Exchange qNMR community provides an authoritative, collaborative forum for scientists to navigate complex instrument calibrations, share validation strategies, and proactively align on evolving regulatory standards for chemical reference materials.

The Multi-Attribute Method (MAM) is a transformative analytical approach for pharmaceutical compliance, leveraging high-resolution liquid chromatography-mass spectrometry (LC-MS) to simultaneously monitor multiple critical quality attributes (CQAs) of complex biotherapeutics. By integrating robust sample preparation workflows and advanced new peak detection (NPD) algorithms, industry professionals utilize MAM to streamline routine quality control processes within cGMP environments and ensure adherence to evolving global expectations, including the USP <1060> chapter. The USP Exchange MAM community serves as an authoritative, collaborative forum for scientists to share implementation strategies, troubleshoot complex bioinformatics software, and drive the global standardization of this advanced analytical methodology.

Discussion about this site, its organization, how it works, and how we can improve it.

Create topics here that don’t fit into any other existing category.